Literature DB >> 2693819

Immunoglobulin therapy in neurologic diseases.

P Berlit1.   

Abstract

An overview is given on the use of immunoglobulins in clinical neurology. While 5S-immunoglobulins may be employed in addition to virostatics in viral encephalitis, 7S-immunoglobulins can be used in autoimmune diseases like myasthenia gravis, multiple sclerosis, and the Guillain-Barré syndrome. Refractory childhood epilepsies like the Lennox-Gastaut syndrome responded to 7S-immunoglobulins. Hyperimmunoglobulins are to be given in bacterial infections in which toxins are formed and in viral infections caused by cytomegalovirus and tick-borne encephalitis virus. While some open studies report benefit from the use of immunoglobulins in neurological diseases, controlled evidence for their efficacy is still missing.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2693819     DOI: 10.1007/bf01716058

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  15 in total

1.  Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy.

Authors:  M Vermeulen; F G van der Meché; J D Speelman; A Weber; H F Busch
Journal:  J Neurol Sci       Date:  1985-10       Impact factor: 3.181

2.  Effects of gamma-globulin therapy in severely epileptic children.

Authors:  R Bedini; M R de Feo; A Orano; L Rocchi
Journal:  Epilepsia       Date:  1985 Jan-Feb       Impact factor: 5.864

3.  The prognosis and long-term course of viral encephalitis.

Authors:  P Berlit
Journal:  J Neuroimmunol       Date:  1988-12       Impact factor: 3.478

4.  High dose gammaglobulin for intractable childhood epilepsy.

Authors:  M Ariizumi; K Baba; H Shiihara; K Ogawa; S Hibio; Y Suzuki; S Ryo; T Momoki
Journal:  Lancet       Date:  1983-07-16       Impact factor: 79.321

5.  [Experiences with intrathecal gamma globulin therapy (author's transl)].

Authors:  B Richling
Journal:  Nervenarzt       Date:  1977-08       Impact factor: 1.214

6.  [Therapeutic value of immunoglobulins in central nervous system infections].

Authors:  I Neu
Journal:  Med Klin       Date:  1980-07-18

7.  Treatment of idiopathic West and Lennox-Gastaut syndromes by intravenous administration of human polyvalent immunoglobulins.

Authors:  K van Rijckevorsel-Harmant; M Delire; M Rucquoy-Ponsar
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

8.  First results of immunotherapy with immunoglobulin G in multiple sclerosis patients.

Authors:  E Schuller; A Govaerts
Journal:  Eur Neurol       Date:  1983       Impact factor: 1.710

9.  Controlled trial of Pseudomonas immunoglobulin and vaccine in burn patients.

Authors:  R J Jones; E A Roe; J L Gupta
Journal:  Lancet       Date:  1980-12-13       Impact factor: 79.321

10.  [Gamma globulin therapy in multiple sclerosis. Theoretical considerations and initial clinical experiences with 7S immunoglobulins in MS therapy].

Authors:  W Soukop; H Tschabitscher
Journal:  Wien Med Wochenschr       Date:  1986-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.